
http://www.crinetics.com
Crinetics Pharmaceuticals, Inc. Company Intro
About: Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. We have assembled a seasoned team with extensive expertise in drug discovery and development in endocrine G-protein coupled receptors (GPCRs) and built a highly productive drug discovery organization.
Industry
Healthcare
Crinetics Pharmaceuticals, Inc. Headquaters
Building No. 2
San Diego,92121
United States
Crinetics Pharmaceuticals, Inc. Share price
17 May 2023 13:01 GMT
$21.88
-0.45 (-2.02 %)
Crinetics Pharmaceuticals, Inc. Market cap
$1.195 B
WMC RANKING
2023
Crinetics Pharmaceuticals, Inc. # 261
BiotechnologyLatest Crinetics Pharmaceuticals, Inc. News
07 Dec 2023
Can Crinetics Pharmaceuticals Inc (CRNX) Stock Rise to the Top of Healthcare Sector Thursday?
Crinetics Pharmaceuticals Inc (CRNX) is around the top of the Healthcare sector according to InvestorsObserver. CRNX received an overall rating of 100,...
07 Dec 2023
Can Crinetics Pharmaceuticals Inc (CRNX) Stock Rise to the Top of Healthcare Sector Thursday?
Additionally, Crinetics Pharmaceuticals Inc scored a 97 in the Healthcare sector, ranking it higher than 97% of stocks in that sector. Overall Score - 100. CRNX...
06 Dec 2023
Der Markt für Somatostatinrezeptoren Typ 4 wächst bis 2030 ...
Hauptakteure auf dem globalen Somatostatin-Rezeptor Typ 4-Markt: Crinetics Pharmaceuticals Inc, Strongbridge Biopharma plc, . Marktsegmentierung nach Produkttyp...
WMC Market Score
WMC Market to Revenue Score
Crinetics Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
Crinetics Pharmaceuticals, Inc. | USD | $0 | $80,089 | $-79,353 | $11,950B | 261 |
Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Crinetics Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Crinetics Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Crinetics Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Crinetics Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Crinetics Pharmaceuticals, Inc. WMC Market Score Calculations
Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
Crinetics Pharmaceuticals, Inc. | 0.01 | 2.21 | 0.06 | 0 | 0 | 0 | 0.98 |
Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge